Year |
Citation |
Score |
2013 |
Madar S, Harel E, Goldstein I, Stein Y, Kogan-Sakin I, Kamer I, Solomon H, Dekel E, Tal P, Goldfinger N, Friedlander G, Rotter V. Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta Plos One. 8. PMID 23630584 DOI: 10.1371/Journal.Pone.0061353 |
0.379 |
|
2011 |
Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V, Berger R. TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model. Plos One. 6: e21650. PMID 21747944 DOI: 10.1371/Journal.Pone.0021650 |
0.31 |
|
2011 |
Kogan-Sakin I, Tabach Y, Buganim Y, Molchadsky A, Solomon H, Madar S, Kamer I, Stambolsky P, Shelly A, Goldfinger N, Valsesia-Wittmann S, Puisieux A, Zundelevich A, Gal-Yam EN, Avivi C, et al. Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells. Cell Death and Differentiation. 18: 271-81. PMID 20689556 DOI: 10.1038/Cdd.2010.94 |
0.34 |
|
2010 |
Sarig R, Rivlin N, Brosh R, Bornstein C, Kamer I, Ezra O, Molchadsky A, Goldfinger N, Brenner O, Rotter V. Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. The Journal of Experimental Medicine. 207: 2127-40. PMID 20696700 DOI: 10.1084/Jem.20100797 |
0.341 |
|
2009 |
Paland N, Kamer I, Kogan-Sakin I, Madar S, Goldfinger N, Rotter V. Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer. Molecular Cancer Research : McR. 7: 1212-23. PMID 19671672 DOI: 10.1158/1541-7786.Mcr-09-0073 |
0.333 |
|
2002 |
Budanov AV, Shoshani T, Faerman A, Zelin E, Kamer I, Kalinski H, Gorodin S, Fishman A, Chajut A, Einat P, Skaliter R, Gudkov AV, Chumakov PM, Feinstein E. Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene. 21: 6017-31. PMID 12203114 DOI: 10.1038/Sj.Onc.1205877 |
0.448 |
|
Show low-probability matches. |